Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab manufactured using its fully integrated continuous manufacturing platform
Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab manufactured using its fully integrated continuous manufacturing platform Mumbai, February…
